| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 11.90 | -0.11 (-0.92%) | 9.24 - 12.01 | 0.0 |
Market data as of 6:05PM 05/22/13. Quotes are delayed by at least 15 min.
The investment seeks long-term growth of capital. The fund seeks to achieve its objective by investing in the equity securities of companies that pass the FFV Scorecard, a proprietary screening methodology developed by Trinity Fiduciary Partners, LLC (the "Adviser"). The starting universe used to select equity securities is the largest 1000 stocks, based on market capitalization, listed on domestic U.S. securities markets. While the fund selects stocks from the 1000 largest companies, the fund may invest in companies of any size, including what are commonly referred to as small-cap and mid-cap companies.
| Total Return | 6.66% |
|---|---|
| Yield (Trailing 12 Mo.) | 0.90% |
| Expense Ratio | 2.38% |
| Front Load | 5.00% |
| Deferred Load | None |
| Minimum Investment | $1,000 |
| Management Tenure | 5 Years |
| Fund Inception | 03/19/2008 |
| Timeframe | EPVAX | S&P 500 | Large Blend |
|---|---|---|---|
| 1 Month | 1.68% | 1.93% | 1.69% |
| 3 Month | 7.18% | 7.18% | 6.59% |
| Year-to-Date | 12.84% | 12.74% | 12.31% |
| 1 Year | 16.76% | 16.89% | 15.95% |
| 3 Year | 11.04% | 12.80% | 11.00% |
| 5 Year | 5.22% | 5.21% | 4.18% |
| 10 Year | -- | 7.88% | 7.49% |
| Since Inception | 6.66% | 10.38% | -- |
| Basic Materials | 2.59% | |
|---|---|---|
| Consumer Cyclical | 16.57% | |
| Financial Services | 10.53% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 9.44% | |
| Healthcare | 15.60% | |
| Utilities | 2.23% | |
| Communication Services | 1.66% | |
| Energy | 10.54% | |
| Industrials | 15.46% | |
| Technology | 15.38% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 91.32 | 91.32 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.00 | 0.00 | ||
| Foreign Stock | -- | 6.70 | 6.70 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 98.02 | 98.02 | ||
| Cash | -- | 1.98 | 1.98 | ||
| Total Net Assets | $14.57M |
|---|---|
| Total Stock Holdings | 54 |
| Total Bond Holdings | 0 |
| Valuation | EPVAX | Category Range |
|---|---|---|
| Price/Earnings | 16.22 | |
| Price/Book | 2.58 | |
| Price/Sales | 1.05 | |
| Price/Cash Flow | 9.76 | |
| Dividend Yield | 2.37 | |
| LT Earnings | 10.63 | |
| Historical Earnings | 16.46 | |
| Sales Growth | 7.4 | |
| Cash-Flow Growth | 7.43 | |
| Book-Value Growth | 9.89 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Avg | |
| Return | Below Avg |
| Pretax Return | 11.04% |
|---|---|
| Tax-adjusted Return | 8.82% |
| Tax Cost Ratio | 0.31% |
| Potential Cap Gains | 20.34% |
